Adam R. Johnson

4.3k citations

49 papers · 1.2k indexed · h-index 21

Cancer Research top 10%
- Protease and Inhibitor Mechanisms 3
Biochemistry top 5%
- Lipid metabolism and biosynthesis 4
Oncology top 10%
- Bone health and treatments 3
Immunology
- Psoriasis: Treatment and Pathogenesis 3
Hematology top 10%
Molecular Biology
- Retinoids in leukemia and cellular processes 6
Genetics
- Chronic Lymphocytic Leukemia Research 3
Nutrition and Dietetics
- Fatty Acid Research and Health 3
Materials Chemistry
- Enzyme Structure and Function 3

Co-authors: A. C. Fogerty Leon Singer Richard D. Dyer F. S. Shenstone W. D. Armstrong Christine Everett R. Bickerstaffe Harvey Wong
Cited by: Cancer Research Biochemistry Oncology
Journals: Science (1 paper)Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (3 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Adam R. Johnson

48 papers receiving 1.2k citations

Peers

Countries citing papers authored by Adam R. Johnson

Since Specialization

Citations

This map shows the geographic impact of Adam R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam R. Johnson more than expected).

Fields of papers citing papers by Adam R. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam R. Johnson. The network helps show where Adam R. Johnson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Adam R. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam R. Johnson Line = papers co-authored together Adam R. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats Journal of Pharmacology and Experimental Therapeutics ·Rebecca I. Erickson,Leah Schutt,Jacqueline M. Tarrant,Michelle McDowell,Lichuan Liu,Adam R. Johnson,Sock-Cheng Lewin-Koh,Maj Hedehus,Jed Ross,Richard A.D. Carano,Karin Staflin,Fiona Zhong,James J. Crawford,Shelly Zhong,Karin Reif,Arna Katewa,Harvey Wong,Wendy B. Young,Donna M. Dambach,Dinah Misner	2016	12
2	Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties Bioorganic & Medicinal Chemistry Letters ·Olivier René,Benjamin P. Fauber,Adrian Barnard,Kerry L. Chapman,Yuzhong Deng,Céline Eidenschenk,Christine Everett,Alberto Gobbi,Adam R. Johnson,Hank La,Maxine Norman,Gary Salmon,Susan Summerhill,Harvey Wong	2016	9
3	Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Alberto Gobbi,Kirk Robarge,Aihe Zhou,Adrian Barnard,Jianhua Cao,Yuzhong Deng,Céline Eidenschenk,Christine Everett,Arunima Ganguli,Julie A. Hawkins,Adam R. Johnson,Hank La,Maxine Norman,Gary Salmon,Susan Summerhill,Wenjun Ouyang,Wei Tang,Harvey Wong	2015	58
4	Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Alberto Gobbi,Pascal Savy,Brenda Burton,Yuzhong Deng,Christine Everett,Hank La,Adam R. Johnson,Peter Lockey,Maxine Norman,Harvey Wong	2015	10
5	Discovery of 1-{4-[3-Fluoro-4-((3 S ,6 R )-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist Journal of Medicinal Chemistry ·Benjamin P. Fauber,Olivier René,Yuzhong Deng,Jason DeVoss,Céline Eidenschenk,Christine Everett,Arunima Ganguli,Alberto Gobbi,Julie A. Hawkins,Adam R. Johnson,Hank La,Justin Lesch,Peter Lockey,Maxine Norman,Wenjun Ouyang,Susan Summerhill,Harvey Wong	2015	46
6	Identification of tertiary sulfonamides as RORc inverse agonists Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Olivier René,Brenda Burton,Christine Everett,Alberto Gobbi,Julie A. Hawkins,Adam R. Johnson,Marya Liimatta,Peter Lockey,Maxine Norman,Harvey Wong	2014	22
7	Reduction in lipophilicity improved the solubility, plasma–protein binding, and permeability of tertiary sulfonamide RORc inverse agonists Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Olivier René,Gladys de Leon Boenig,Brenda Burton,Yuzhong Deng,Céline Eidenschenk,Christine Everett,Alberto Gobbi,S.G. Hymowitz,Adam R. Johnson,Hank La,Marya Liimatta,Peter Lockey,Maxine Norman,Wenjun Ouyang,Weiru Wang,Harvey Wong	2014	39
8	Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc Bioorganic & Medicinal Chemistry Letters ·Benjamin P. Fauber,Gladys de Leon Boenig,Brenda Burton,Céline Eidenschenk,Christine Everett,Alberto Gobbi,S.G. Hymowitz,Adam R. Johnson,Marya Liimatta,Peter Lockey,Maxine Norman,Wenjun Ouyang,Olivier René,Harvey Wong	2013	49
9	Gastrocnemius Recession or Tendo-Achilles Lengthening for Equinus Deformity in the Diabetic Foot? Clinics in Podiatric Medicine and Surgery ·Robert M. Greenhagen,Adam R. Johnson,Nicholas J. Bevilacqua	2012	27
10	The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site Structure ·G. de Leon-Boenig,Krista K. Bowman,Jianwen A. Feng,Terry D. Crawford,Christine Everett,Yvonne Franke,Angela Oh,Mark Stanley,Steven T. Staben,Melissa A. Starovasnik,Heidi J.A. Wallweber,Jian Wu,Lawren C. Wu,Adam R. Johnson,S.G. Hymowitz	2012	50
11	Case Studies of Minimizing Nonspecific Inhibitors in HTS Campaigns That Use Assay-Ready Plates SLAS DISCOVERY ·Yichin Liu,Maureen H. Beresini,Adam R. Johnson,Robert A. Mintzer,Kinjalkumar Shah,Kevin Clark,Stephen Schmidt,Cristina Lewis,Marya Liimatta,Linda O. Elliott,Amy Gustafson,Christopher E. Heise	2011	7
12	Idiopathic loss of deciduous teeth and associated alveolus UCL Discovery (University College London) ·Seema Singh Koshal,S. I. Chaudhry,Adam R. Johnson,(unknown)	2010	2
13	Gastrocnemius Recession as an Alternative to TendoAchillis Lengthening for Relief of Forefoot Pressure in a Patient with Peripheral Neuropathy: A Case Report and Description of a Technical Modification The Journal of Foot & Ankle Surgery ·Robert M. Greenhagen,Adam R. Johnson,Matthew C. Peterson,Lee C. Rogers,Nicholas J. Bevilacqua	2010	24
14	Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects Journal of Biological Chemistry ·Adam R. Johnson,A.G. Pavlovsky,Daniel F. Ortwine,Faith Prior,Chiu-Fai Man,Dirk A. Bornemeier,Craig Banotai,W. Thomas Mueller,Patrick McConnell,Chunhong Yan,Vijay Baragi,Charles A. Lesch,W. Howard Roark,Michael J. Wilson,Kaushik Datta,Roberto E. Guzman,Hyo‐Kyung Han,Richard D. Dyer	2007	176
15	A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition Journal of Biological Chemistry ·Linda L. Johnson,A.G. Pavlovsky,Adam R. Johnson,Jeffrey A. Janowicz,Chiu-Fai Man,Daniel F. Ortwine,Claude F. Purchase,Andrew D. White,Donald Hupe	2000	64
16	Site-Directed Mutagenesis of Histidine-90 inEscherichia colil-Threonine Dehydrogenase Alters Its Substrate Specificity Archives of Biochemistry and Biophysics ·Adam R. Johnson,Eugene E. Dekker	1998	9
17	Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on β-adrenoceptors in rat brain: Autoradiographic and functional studies Neuropharmacology ·David J. Nelson,Gerard D. Pratt,K PALMER,Adam R. Johnson,Norman G. Bowery	1991	20
18	Influence of nutritional factors on the yield and content of milk fat: protected polyunsaturated fat in the diet. Bulletin. International Dairy Federation ·A. C. Fogerty,Adam R. Johnson	1980	6
19	Inhibition by cyclopropene fatty acids of the desaturation of stearic acid in hen liver Lipids ·E. Allen,Adam R. Johnson,A. C. Fogerty,Judith A. Pearson,F. S. Shenstone	1967	60
20	The relationship of calcium and strontium in the mineralized tissues of the rat: replacement and exchange of these elements in vivo and in vitro. Adam R. Johnson	1966	1

About Adam R. Johnson

Adam R. Johnson is a scholar working on Biochemistry, Equine and Oncology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (6 papers), Lipid metabolism and biosynthesis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Protease and Inhibitor Mechanisms (3 papers), Fatty Acid Research and Health (3 papers), Enzyme Structure and Function (3 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Cancer Research (263 citations), Biochemistry (91 citations) and Oncology (300 citations). Adam R. Johnson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include A. C. Fogerty, Leon Singer, Richard D. Dyer, F. S. Shenstone, W. D. Armstrong, Christine Everett, R. Bickerstaffe, Harvey Wong, Judith A. Pearson and Alberto Gobbi. Their work appears in journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact